Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.
Ma, B., Bohnert, T., Otipoby, K.L., Tien, E., Arefayene, M., Bai, J., Bajrami, B., Bame, E., Chan, T.R., Humora, M., MacPhee, J.M., Marcotte, D., Mehta, D., Metrick, C.M., Moniz, G., Polack, E., Poreci, U., Prefontaine, A., Sheikh, S., Schroeder, P., Smirnakis, K., Zhang, L., Zheng, F., Hopkins, B.T.(2020) J Med Chem 63: 12526-12541
- PubMed: 32696648 
- DOI: 10.1021/acs.jmedchem.0c00702
- Primary Citation of Related Structures:  
6VXQ, 6W06, 6W07 - PubMed Abstract: 
Autoreactive B cell-derived antibodies form immune complexes that likely play a pathogenic role in autoimmune diseases. In systemic lupus erythematosus (SLE), these antibodies bind Fc receptors on myeloid cells and induce proinflammatory cytokine production by monocytes and NETosis by neutrophils ...